Registered entities
Denali Therapeutics Inc.
Reg. No. 1714899United States
DENALI THERAPEUTICS, INC.
Reg. No. 463872213United States
Innovation
135 patent families (38 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 8,043 times.
| Year | Filings |
|---|---|
| 2017 | 7 |
| 2018 | 19 |
| 2019 | 32 |
| 2020 | 35 |
| 2021 | 44 |
| 2022 | 46 |
| 2023 | 65 |
| 2024 | 69 |
| 2025 | 53 |
| 2026 | 16 |
Social engagement
Social engagement: 64.7K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
12 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 67% |
| Private equity | 1 | 8% |
| Other / undisclosed | 3 | 25% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
10 Mar 2026 · Associate Director, Clinical Pharmacology · South San Francisco
10 Oct 2025 · Denali Therapeutics is hiring: Senior Director, Regulatory Advertising and Promo · South San Francisco
1 Oct 2025 · Sr. Quality Assurance Specialist · Salt Lake City
10 Nov 2024 · Data Engineer/Permanent(Full-Time) · null
Based on job postings tracked across public sources.
Recent activity
6 May 2026
Event
TIDES: Oligonucleotides and Peptide Therapeutics Conference
26 Mar 2026
Milestone
regulatory
25 Mar 2026
Milestone
regulatory